Skip to main content
Veterinary Medicines

SYNULOX 140 mg/ml + 35 mg/ml suspensión inyectable

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate

Product identification

Medicine name:
SYNULOX 140 mg/ml + 35 mg/ml suspensión inyectable
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Cattle
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    140.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Potassium clavulanate
    35.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        54
        day
    • Pig
      • Meat and offal
        27
        day
    • Cattle
      • Milk
        108
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Spain S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 450 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 1/02/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 1/02/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 1/02/2024